Insider · CIK 0001938709

Casdin Partners Fo1-Msv, LP

CIK 0001938709 Name as filed on the most recent filing

Filed as Casdin Partners Fo1-Msv, LP (10)

21 transaction lines · from 10 filings · filed 2023-05-19 to 2024-06-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-06-04 P, Open-market purchase GeneDx Holdings Corp.WGS 675,477, acquired Open Form 4 filing 0000919574-24-003510
2024-06-03 P, Open-market purchase GeneDx Holdings Corp.WGS 2,081,640, acquired Open Form 4 filing 0000919574-24-003510
2024-05-29 P, Open-market purchase GeneDx Holdings Corp.WGS 842,604, acquired Open Form 4 filing 0000919574-24-003432
2024-05-28 P, Open-market purchase GeneDx Holdings Corp.WGS 377,167, acquired Open Form 4 filing 0000919574-24-003355
2024-05-24 P, Open-market purchase GeneDx Holdings Corp.WGS 2,900,906, acquired Open Form 4 filing 0000919574-24-003355
2024-05-23 P, Open-market purchase Standard Biotools Inc.LAB 260,000, acquired Open Form 4 filing 0000919574-24-003356
2024-05-23 P, Open-market purchase GeneDx Holdings Corp.WGS 146,916, acquired Open Form 4 filing 0000919574-24-003355
2024-05-22 P, Open-market purchase Standard Biotools Inc.LAB 387,735, acquired Open Form 4 filing 0000919574-24-003308
2024-05-21 P, Open-market purchase Standard Biotools Inc.LAB 895,930, acquired Open Form 4 filing 0000919574-24-003308
2024-05-20 P, Open-market purchase Standard Biotools Inc.LAB 258,130, acquired Open Form 4 filing 0000919574-24-003308
2024-05-17 P, Open-market purchase Standard Biotools Inc.LAB 902,044, acquired Open Form 4 filing 0000919574-24-003252
2024-05-16 P, Open-market purchase Standard Biotools Inc.LAB 1,270,950, acquired Open Form 4 filing 0000919574-24-003252
2024-05-15 P, Open-market purchase Standard Biotools Inc.LAB 1,282,550, acquired Open Form 4 filing 0000919574-24-003252
2024-05-13 P, Open-market purchase GeneDx Holdings Corp.WGS 1,165,295, acquired Open Form 4 filing 0000919574-24-003212
2024-03-05 P, Open-market purchase GeneDx Holdings Corp.WGS 7,944, acquired Open Form 4 filing 0000919574-24-001889
2024-03-05 P, Open-market purchase Standard Biotools Inc.LAB 3,669, acquired Open Form 4 filing 0000919574-24-001888
2024-03-04 P, Open-market purchase GeneDx Holdings Corp.WGS 349,708, acquired Open Form 4 filing 0000919574-24-001889
2024-03-04 P, Open-market purchase Standard Biotools Inc.LAB 642,500, acquired Open Form 4 filing 0000919574-24-001888
2023-05-19 P, Open-market purchase Standard Biotools Inc.LAB 1,835,920, acquired Open Form 4 filing 0000919574-23-003425
2023-05-18 P, Open-market purchase Standard Biotools Inc.LAB 323,865, acquired Open Form 4 filing 0000919574-23-003425
2023-05-17 P, Open-market purchase Standard Biotools Inc.LAB 471,550, acquired Open Form 4 filing 0000919574-23-003425

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Casdin Partners FO1-MSV, LP, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001938709

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.